glp-1 and binge eating disorder obesity drugs disorders are not well understood yet : NPR New hope for binge eating

At the same time, the percentage of adult patients who had bariatric and metabolic surgery (BM

N = 161,798 after matching GLP-1RA vs diet/exercise consultation Median follow-up: 2 years Key result: Any obesity-associated cancer HR 0.59, 95% CI 0.53-0.67 Site-specific signals: Multiple myeloma HR 0.37 Pancreatic cancer HR 0.40 Endometrial cancer HR 0.42 Colorectal cancer HR 0.49 But remember: This is observational

Updated Virtual Weight Loss Platform Expands Access to GLP-1 Support and Clinician-Guided Obesity Care Across All 50 StatesSAN FRANCISCO, June 10, 2025 (GLOBE NEWSWIRE) -- Mochi Health, a physician-founded telehealth company delivering medical weight loss care directly to patients, announced today the launch of its newly upgraded online platform

No synthetic FD&C dyes

As expanded insurance coverage is expected to significantly improve access to costly therapies, substantial changes are anticipated across both the obesity treatment market and broader healthcare paradigms.

The interaction between GLP-1RAs and gut microbiota introduces a novel pharmaco-gut interface, emphasizing the role of microbial composition in drug response